المؤلفون: Hammarström, Klara, Nunes, Luis, Mathot, Lucy, Lundin, Emma, Korsavidou Hult, Nafsika Dimitra, Mezheyeuski, Artur

المساهمون: Institut Català de la Salut, Hammarström K, Nunes L, Mathot L, Lundin E Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Mezheyeuski A Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Korsavidou Hult N Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Recte - Càncer - Recaiguda, Recte - Càncer - Quimioteràpia, Recte - Càncer - Radioteràpia, Anomalies cromosòmiques, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Chemoradiotherapy, PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation, DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms::Rectal Neoplasms, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Neoadjuvant Therapy, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::quimiorradioterapia, FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales::neoplasias del recto, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::tratamiento neoadyuvante, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local

وصف الملف: application/pdf

العلاقة: International Journal of Cancer;155(1); https://doi.org/10.1002/ijc.34880Test; Hammarström K, Nunes L, Mathot L, Mezheyeuski A, Lundin E, Korsavidou Hult N, et al. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer. Int J Cancer. 2024 Jul 1;155(1):40–53.; https://hdl.handle.net/11351/11484Test; 001166000400001

الإتاحة: https://doi.org/10.1002/ijc.34880Test
https://hdl.handle.net/11351/11484Test

المؤلفون: Tolaney, Sara M, Loirat, Delphine, Punie, Kevin, Hurvitz, Sara, Cortés Castan, Javier, Rugo, Hope, Bardia, Aditya

المساهمون: Institut Català de la Salut, Rugo HS Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Tolaney SM Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Loirat D Department of Medical Oncology and D3i, Institut Curie, Paris, France. Punie K Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. Bardia A Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Hurvitz SA Medical Oncology, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. Cortés J International Breast Cancer Center (IBCC), Quiron Group, Madrid & Barcelona, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Mama - Càncer - Tractament, Metàstasi, Medicaments antineoplàstics - Ús terapèutic, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms::Triple Negative Breast Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama::neoplasias de mama triple negativos, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local

وصف الملف: application/pdf

العلاقة: npj Breast Cancer;8; https://doi.org/10.1038/s41523-022-00467-1Test; Rugo HS, Tolaney SM, Loirat D, Punie K, Bardia A, Hurvitz SA, et al. Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer. npj Breast Cancer. 2022 Aug 29;8:98.; https://hdl.handle.net/11351/8358Test; 000847340700002

الإتاحة: https://doi.org/10.1038/s41523-022-00467-1Test
https://hdl.handle.net/11351/8358Test

المؤلفون: Bruzas, Simona, Gluz, Oleg, Harbeck, Nadia, Cortés Castan, Javier, Blohmer, Jens-Uwe, Schmid, Peter

المساهمون: Institut Català de la Salut, Bruzas S Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany. Gluz O West German Study Group, Moenchengladbach, Germany. Breast Center Niederrhein, Evangelical Hospital Bethesda, Moenchengladbach, Germany. Harbeck N Breast Center, Dept. OB&GYN and CCCLMU, University of Munich (LMU), Munich, Germany. Schmid P Barts Cancer Institute, Queen Mary University London, London, United Kingdom. Cortés J International Breast Cancer Centre (IBCC), Quiron Group, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA. Blohmer J Klinik für Gynäkologie mit Brustzentrum, Charité-Universitätsmedizin Berlin, Berlin, Germany, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Mama - Càncer - Aspectes genètics, Mama - Càncer - Recaiguda, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms, Other subheadings::Other subheadings::Other subheadings::/genetics, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, Otros calificadores::Otros calificadores::Otros calificadores::/genética, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local

وصف الملف: application/pdf

العلاقة: NPJ Breast Cancer;8; https://doi.org/10.1038/s41523-022-00403-3Test; Bruzas S, Gluz O, Harbeck N, Schmid P, Cortés J, Blohmer J, et al. Gene signatures in patients with early breast cancer and relapse despite pathologic complete response. NPJ Breast Cancer. 2022 Mar 29;8:42.; https://hdl.handle.net/11351/8003Test; 000774915300001

الإتاحة: https://doi.org/10.1038/s41523-022-00403-3Test
https://hdl.handle.net/11351/8003Test

المؤلفون: Berlanga, Pablo, Pierron, Gaelle, Lacroix, Ludovic, Chicard, Mathieu, Adam de Beaumais, Tiphaine, Marchais, Antonin, Soriano Fernández, Aroa, Hladun Alvaro, Raquel

المساهمون: Institut Català de la Salut, Berlanga P Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Pierron G Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France. Lacroix L Department of Pathology and Laboratory Medicine, Translational Research Laboratory and Biobank, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Chicard M INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Research Center, PSL Research University, Institut Curie, Paris, France. Adam de Beaumais T Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Marchais A INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Soriano Fernandez A Grup de Recerca Translacional en Càncer en la Infància i l’Adolescència, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Hladun-Alvaro R Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Càncer - Recaiguda, Medicina personalitzada, Pediatria, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Precision Medicine, DISEASES::Neoplasms, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::medicina de precisión, ENFERMEDADES::neoplasias

وصف الملف: application/pdf

العلاقة: Cancer Discovery;12(5); https://doi.org/10.1158/2159-8290.CD-21-1136Test; Berlanga P, Pierron G, Lacroix L, Chicard M, Adam de Beaumais T, Marchais A, et al. The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies. Cancer Discov. 2022 May 1;12(5):1266–81.; https://hdl.handle.net/11351/8044Test; 000795663800001

الإتاحة: https://doi.org/10.1158/2159-8290.CD-21-1136Test
https://hdl.handle.net/11351/8044Test

المؤلفون: Shah, Jennifer, Pueschl, Dana, Wubbenhorst, Bradley, Fan, Mengyao, Pluta, John, D’Andrea, Kurt, Llop Guevara, Alba, Serra Elizalde, Violeta, Balmaña Gelpí, Judith

المساهمون: Institut Català de la Salut, Shah JB, Pueschl D, Wubbenhorst B, Fan M, Pluta J, D'Andrea K Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Llop Guevara A, Serra V Experimental Therapeutics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Balmaña J Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Anomalies cromosòmiques, Mama - Càncer - Recaiguda, Ovaris - Càncer - Recaiguda, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms, DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación

وصف الملف: application/pdf

العلاقة: Nature Communications;13; https://doi.org/10.1038/s41467-022-34523-yTest; info:eu-repo/grantAgreement/ES/PE2017-2020/CPII19%2F00033; Shah JB, Pueschl D, Wubbenhorst B, Fan M, Pluta J, D’Andrea K, et al. Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. Nat Commun. 2022 Nov 7;13:6728.; https://hdl.handle.net/11351/8553Test

الإتاحة: https://doi.org/10.1038/s41467-022-34523-yTest
https://hdl.handle.net/11351/8553Test

المؤلفون: Lazar, Vladimir, Girard, Nicolas, Raymond, Eric, Martini, Jean-François, Galbraith, Susan, Raynaud, Jacques, Felip Font, Enriqueta, Tabernero Caturla, Josep

المساهمون: Institut Català de la Salut, Lazar V, Raynaud J Worldwide Innovative Network—WIN Consortium, Villejuif, France. Girard N Institut Curie, Paris, France. Institut du Thorax Curie—Institut Montsouris, Paris, France. Raymond E Groupe Hospitalier Saint-Joseph, Paris, France. Martini JF Pfizer Inc, San Diego, CA. Galbraith S AstraZeneca Plc, Cambridge, United Kingdom. Felip E, Tabernero J Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pulmons - Càncer - Tractament, Transcriptomes, Pulmons - Càncer - Recaiguda, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, PHENOMENA AND PROCESSES::Genetic Phenomena::Gene Expression::Transcription, Genetic::Genetic Phenomena::Transcriptome, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, FENÓMENOS Y PROCESOS::fenómenos genéticos::expresión génica::transcripción genética::fenómenos genéticos::transcriptoma, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local

وصف الملف: application/pdf

العلاقة: JCO Precision Oncology;6; https://doi.org/10.1200/PO.22.00072Test; Lazar V, Girard N, Raymond E, Martini JF, Galbraith S, Raynaud J, et al. Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies. JCO Precis Oncol. 2022 Sep 15;6:e2200072.; https://hdl.handle.net/11351/8345Test

الإتاحة: https://doi.org/10.1200/PO.22.00072Test
https://hdl.handle.net/11351/8345Test

المؤلفون: Bobillo Varela, Sabela, Joffe, Erel, Sermer, David, Mondello, Patrizia, Ghione, Paola, Caron, Philip C.

المساهمون: Institut Català de la Salut, Bobillo S Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Joffe E, Sermer D, Mondello P, Ghione P, Caron PC Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cèl·lules B - Tumors - Tractament, Càncer - Recaiguda, Sang - Malalties - Diagnòstic, DISEASES::Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local

وصف الملف: application/pdf

العلاقة: Blood Cancer Journal;11; https://doi.org/10.1038/s41408-021-00506-3Test; Bobillo S, Joffe E, Sermer D, Mondello P, Ghione P, Caron PC, et al. Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse. Blood Cancer J. 2021 Jun 16;11:113.; https://hdl.handle.net/11351/7097Test; 000664631700003

الإتاحة: https://doi.org/10.1038/s41408-021-00506-3Test
https://hdl.handle.net/11351/7097Test

المؤلفون: Delara, Ritchie, Yang, Jie, Suarez Salvador, Elena, Vora, Sujay, Magriña, Javier, Butler, Kristina

المساهمون: Institut Català de la Salut, Delara R, Yang J, Magriña J, Butler K Department of Obstetrics and Gynecology, Mayo Clinic, Phoenix, AZ. Suárez-Salvador E Department of Obstetrics and Gynecology, Mayo Clinic, Phoenix, AZ. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vora S Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Aparell genital femení - Càncer - Cirurgia, Aparell genital femení - Càncer - Radioteràpia, Extirpació (Cirurgia), DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female, Other subheadings::Other subheadings::Other subheadings::/radiotherapy, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, Other subheadings::Other subheadings::Other subheadings::/surgery, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos, Otros calificadores::Otros calificadores::Otros calificadores::/radioterapia, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Otros calificadores::Otros calificadores::Otros calificadores::/cirugía

وصف الملف: application/pdf

العلاقة: Mayo Clinic Proceedings: Innovations, Quality & Outcomes;5(6); https://doi.org/10.1016/j.mayocpiqo.2021.10.004Test; Delara R, Yang J, Suárez-Salvador E, Vora S, Magriña J, Butler K, et al. Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review. Mayo Clin Proc Innov Qual Outcomes. 2021 Nov 19;5(6):1081–8.; https://hdl.handle.net/11351/7594Test

الإتاحة: https://doi.org/10.1016/j.mayocpiqo.2021.10.004Test
https://hdl.handle.net/11351/7594Test

المؤلفون: Swisher, Elizabeth M., Kwan, Tanya T., Oza, Amit M., Tinker, Anna V., Ray-Coquard, Isabelle, Oaknin Benzaquen, Ana Mazaltob

المساهمون: Institut Català de la Salut, Swisher EM University of Washington, Seattle, WA, USA. Kwan TT Clovis Oncology, Inc., Boulder, CO, USA. Oza AM Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Tinker AV BC Cancer—Vancouver, Vancouver, BC, Canada. Ray-Coquard I GINECO, Centre Léon Bérard and University Claude Bernard, Lyon, France. Oaknin A Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Ovaris - Càncer - Tractament, Ovaris - Càncer - Recaiguda, DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local

وصف الملف: application/pdf

العلاقة: Nature Communications;12; https://doi.org/10.1038/s41467-021-22582-6Test; Swisher EM, Kwan TT, Oza AM, Tinker AV, Ray-Coquard I, Oaknin A, et al. Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2). Nat Commun. 2021 May 3;12:2487.; https://hdl.handle.net/11351/6853Test; 000656508100001

الإتاحة: https://doi.org/10.1038/s41467-021-22582-6Test
https://hdl.handle.net/11351/6853Test

المؤلفون: Oza, Amit M., Lorusso, Domenica, Oaknin Benzaquen, Ana Mazaltob, Dean, Andrew, Colombo, Nicoletta, Aghajanian, Carol

المساهمون: Institut Català de la Salut, Oza AM Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Lorusso D Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Aghajanian C Memorial Sloan Kettering Cancer Center, New York, NY. Oaknin A Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Dean A St John of God Subiaco Hospital, Subiaco, WA, Australia. Colombo N University of Milan-Bicocca and European Institute of Oncology, Milan, Italy, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Ovaris - Tumors, Medicaments antineoplàstics - Ús terapèutic, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Carcinoma, Ovarian Epithelial, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma epitelial de ovario, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local

وصف الملف: application/pdf

العلاقة: Journal of Clinical Oncology;38(30); https://doi.org/10.1200/JCO.19.03107Test; Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, et al. Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma. J Clin Oncol. 2020 Oct 20;38(30):3494-3505.; https://hdl.handle.net/11351/6307Test; 000580555400004

الإتاحة: https://doi.org/10.1200/JCO.19.03107Test
https://hdl.handle.net/11351/6307Test